Sec. 1369.353. CRITERIA FOR DRUGS ON MAXIMUM ALLOWABLE COST LISTS. A health benefit plan issuer or pharmacy benefit manager may not include a drug on a maximum allowable cost list unless:
(1) the drug:
(A) has an "A" or "B" rating in the most recent version of the United States Food and Drug Administration's Approved Drug Products with Therapeutic Equivalence Evaluations, also known as the Orange Book; or
(B) is rated "NR" or "NA" or has a similar rating by a nationally recognized reference; and
(2) the drug is:
(A) generally available for purchase by pharmacists and pharmacies in this state from a national or regional wholesaler; and
(B) not obsolete.
Added by Acts 2015, 84th Leg., R.S., Ch. 596 (S.B. 332), Sec. 1, eff. January 1, 2016.
Section: Previous 1369.302 1369.303 1369.304 1369.305 1369.306 1369.351 1369.352 1369.353 1369.354 1369.355 1369.356 1369.357 1369.358 1369.359 1369.360 NextLast modified: September 28, 2016